Korean researchers are delving "into new technologies for creating human st em cells without using embryos," according to Professor Han Yong-Mahn.

Conclusions: This will be the first randomized, double-blind, placebo-controlled clinical trial to assess the clinical efficacy of nesiritide in human ST-segment-elevation anterior AMI.